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BIOCHEMICAL JOURNAL
4‐Hydroxylphenylpyruvate	 dioxygenase	 (HPPD)	 is	 a	 non‐haem	 iron(II)‐dependent	
oxygenase	 that	 catalyzes	 the	 conversion	 of	 4‐hydroxylphenylpyruvate	 (HPP)	 to	
homogentisate	 (HG).	 In	 the	 active	 site,	 a	 strictly	 conserved	 2‐His‐1‐Glu	 facial	 triad	
coordinates	 the	 iron	 ready	 for	 catalysis.	 Substitution	 of	 these	 residues	 resulted	 in	
about	 a	 10‐fold	 decrease	 in	 the	metal	 binding	 affinity,	 as	measured	 by	 isothermal	
titration	 calorimetry,	 and	 a	 large	 reduction	 in	 enzyme	 catalytic	 efficiencies.	 This	
study	revealed	 the	vital	 role	of	 the	 ligand	E349	 in	enzyme	 function.	Substitution	of	
this	 residue	by	 alanine	 resulted	 in	 loss	 of	 activity.	 The	E349G	variant	 retained	5%	
activity	for	the	coupled	reaction,	suggesting	that	coordinating	water	may	be	able	to	
support	activation	of	the	trans	bound	dioxygen	upon	substrate	binding.	The	reaction	
catalyzed	by	the	H183A	variant	was	fully	uncoupled.	H183A	variant	catalytic	activity	
resulted	 in	 protein	 cleavage	 between	 Ile267	 Ala268	 and	 the	 production	 of	 an	 N‐
terminal	fragment.	The	H266A	variant	was	able	to	produce	4‐hydroxyphenylacetate	
(HPA),	 demonstrating	 that	 decarboxylation	 had	 occurred	 but	 that	 there	 was	 no	
subsequent	 product	 formation.	 Structural	 modeling	 of	 the	 variant	 enzyme	 with	
bound	 dioxygen	 revealed	 the	 rearrangement	 of	 the	 coordination	 environment	 and	
the	 dynamic	 behaviour	 of	 bound	 dioxygen	 in	 the	 H266A	 and	 H183A	 variants,	
respectively.	 These	models	 suggest	 that	 the	 residues	 regulate	 the	 geometry	 of	 the	
reactive	 oxygen	 intermediate	 during	 the	 oxidation	 reaction.	 The	 mutagenesis	 and	
structural	simulation	studies	demonstrate	the	critical	and	unique	role	of	each	ligand	
in	 the	 function	 of	 HPPD,	 and	 which	 correlates	 with	 their	 respective	 coordination	
position.		
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Abstract 
4-Hydroxylphenylpyruvate dioxygenase (HPPD) is a non-haem iron(II)-dependent oxygenase 
that catalyzes the conversion of 4-hydroxylphenylpyruvate (HPP) to homogentisate (HG). In the 
active site, a strictly conserved 2-His-1-Glu facial triad coordinates the iron ready for catalysis. 
Substitution of these residues resulted in about a 10-fold decrease in the metal binding affinity, as 
measured by isothermal titration calorimetry, and a large reduction in enzyme catalytic 
efficiencies. This study revealed the vital role of the ligand E349 in enzyme function. 
Substitution of this residue by alanine resulted in loss of activity. The E349G variant retained 5% 
activity for the coupled reaction, suggesting that coordinating water may be able to support 
activation of the trans bound dioxygen upon substrate binding. The reaction catalyzed by the 
H183A variant was fully uncoupled. H183A variant catalytic activity resulted in protein cleavage 
between Ile267 Ala268 and the production of an N-terminal fragment. The H266A variant was able 
to produce 4-hydroxyphenylacetate (HPA), demonstrating that decarboxylation had occurred but 
that there was no subsequent product formation. Structural modeling of the variant enzyme with 
bound dioxygen revealed the rearrangement of the coordination environment and the dynamic 
behaviour of bound dioxygen in the H266A and H183A variants, respectively. These models 
suggest that the residues regulate the geometry of the reactive oxygen intermediate during the 
oxidation reaction. The mutagenesis and structural simulation studies demonstrate the critical and 
unique role of each ligand in the function of HPPD, and which correlates with their respective 
coordination position.  
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Introduction 
4-Hydroxylphenylpyruvate dioxygenase (HPPD, EC 1.13.11.27) is an important enzyme in 
the tyrosine catabolic pathway, which catalyzes the oxidative conversion of 
4-hydroxyphenylpyruvate (HPP) to homogentisate (HG) with concomitant release of CO2. 
Mutations in the encoding gene of human HPPD result in metabolic disorders [1-3]. The enzyme 
is also a molecular target for potent herbicides because in plants the HG product is an essential 
precursor for the biosynthesis of redox cofactors such as plastoquinones and tocochromanols 
[4-7].  
HPPD is a member of the non-haem Fe(II)/2-oxoacid-dependent oxygenase family. The 
majority of these enzymes catalyze the oxidative decarboxylation of 2-oxoglutarate (2-OG) to 
generate a high-energy iron species, which is subsequently used to effect substrate oxidation. In 
the case of HPPD, the 2-oxoacid is not contained within a cosubstrate but is located within the 
pyruvate moiety of the HPP substrate molecule. The catalytic mechanism for the enzyme is 
complicated and not fully understood, but it is proposed to involve oxidative decarboxylation of 
HPP using dioxygen to yield HPA and a high reactive Fe(IV)-oxo intermediate. The latter 
mediates hydroxylation of the aromatic ring, which is followed by a 1,2-shift of the acetyl group 
to form the HG product [8, 9] (Fig. 1A). During this reaction two atoms of oxygen from 
dioxygen are incorporated into the product, in the aromatic hydroxyl group and the carboxyl 
group [10].  
Mononuclear non-haem iron(II) enzymes catalyze a diverse range of oxidative reactions but 
share a strictly conserved structural motif, the  2-His-1-carboxylate (Asp/Glu) facial triad, which 
is used to coordinate the active site metal [11]. Many of these enzymes, including 
deacetoxycephalosporin C synthase, clavaminic acid synthase, and taurine/2-OG dioxygenase, 
are folded into the conserved “jellyroll” protein fold [12-14]. Recently, a number of crystal 
structures revealed flexibility in the metal coordination in other non-haem iron oxygenase 
belonging to the cupin protein family [15-19]. These enzymes coordinate the metal centre in 
different ways to the classical 2His-1-carboxylate motif, with changes including the replacement 
of the coordinated carboxylate by a histidine, coordination of the iron through two, three or four 
histidine residues, or coordination by three histidines and one glutamate. These types of 
coordination are found in the protein structures of halogenase, cysteine dioxygenase, carotene 
oxygenase and quercetin dioxygenase, respectively [20-23]. Changing metal coordination might 
result in a change in mechanism for these non-haem iron-dependent enzymes.  
The critical role of the 2-His-1-carboxylate motif as the Fe2+ binding ligands in these 
enzymes has been confirmed by site-directed mutagenesis, supporting the crystallographic 
studies [24-27]. Interestingly, the carboxylate variants of the Factor Inhibiting Hypoxia-Inducible 
Factor (FIH) exhibited turnover of 2-OG, in particular the D201G variant. This variant was able 
to coupled 2-OG turnover with hydroxylation of the peptide substrate [27]. The crystal structure 
of the variant FIH in complex with the peptide substrate demonstrated that two His residues 
alone are sufficient to coordinate the metal within the active site in this enzyme. The binding 
manner resembles that observed in the reported structure of non-haem iron-dependent halogenase 
SyrB2, in which the carboxylate ligand is replaced by a halide ion [20]. These studies highlight 
the potential structural flexibility of the facial triad in metal coordination.  
Unlike the jellyroll motif in 2-OG dependent oxygenases, HPPD is topologically similar to 
the extradiol dioxygenases with two barrel-shaped domains [28, 29]. The active site of HPPD is 
located in the C-terminal domain, which is buried within the -barrel structure containing a 
similar triad motif for metal binding [30-34]. The metal coordination ligands of His183, His266 
and Glu349 are strictly conservative across the HPPD homologues, although their overall 
sequences share less than 30% identity (Fig. 1B). These three ligands were ligated to iron in a 
five-coordinate, distorted square-pyramidal arrangement or octahedral geometry, as reported in 
the ternary complex structure of HPPD from S. avermitilis and R. novegicus, respectively [30, 
34]. In these structures, the two oxygen atoms of the inhibitor coordinate to the metal ion trans to 
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the His and Glu ligands, respectively. Similar coordination geometries were observed in the 
structure of the hydroxymandelate synthase (HMS)-4-hydroxymandelate (HMA) complex, in 
which a distorted trigonal bipyramidal arrangement is found. HMS is related to HPPD and 
catalyzes the conversion of the HPP substrate to HMA [35]. The arrangement of ligands and 
inhibitor/HMA in metal coordination is similar to that of other 2-OG dependent oxygenases and 
the O2 is assumed to occupy the sixth binding site of the metal [12, 36, 37]. Although the 
structure of HPPD in complex with HPP is not available, recent site-directed mutagenesis studies 
of active site residues and quantum mechanical/molecular mechanical (QM/MM) theoretical 
calculations have shed light on the binding of HPP in the active site of carrot HPPD [38]. In this 
model, the HPP is coordinated in a different arrangement in which the oxygen atoms of 
carboxylate and keto groups of HPP bind trans to 2 His ligands, and the dioxygen molecule is 
assumed to bind opposite to the Glu ligand. Structural, spectroscopic and computational studies 
have suggested that the binding of substrate activates the metal centre to attack by dioxygen [14, 
16, 17, 19, 39]. The donor interaction of the 2-oxoacid with the metal primes the activation of 
dioxygen by the metal [40]. Although the binding site of dioxygen molecule in the facial triad is 
flexible as revealed by structural studies, the relationship between the reactivity of the bound 
dioxygen and the identity of the respective trans ligand remains unclear [14, 16, 17, 19].  
To better understand the contribution of facial triad to the properties of metal coordination 
and enzyme function, mutation analysis of human HPPD was carried out. This study revealed 
that one Glu and one His residue but not two His residues are sufficient for catalytic function. 
The Glu ligand in the triad plays a critical role in catalytic function and the His ligands regulate 
the coupling of the reaction and avoid other possible side reactions.    
 
Experimental Procedures  
Materials 
The QuikChange mutagenesis kit was purchased from Stratagene. Q-Sepharose, SOURCE 
15PHE and Sephacryl HR-100 were obtained from GE Healthcare. All other chemicals and 
buffers were purchased from the Merck, the Sigma-Aldrich Chemical Co. or J. T. Baker and were 
of the highest purity available. Aqueous solutions were made up in Milli-Q 18.2 MΩ cm-1 water 
and pH adjusted with NaOH or HCl. Solutions and equipment for molecular biology were 
purchased sterile or sterilized by autoclaving at 121ºC and 15 PSI for 20 minutes or filtration 
through a 0.22 μ filter. 
 
Site-directed mutagenesis 
The variants of H183A, H266A, E349A, E349G, and E349Q were generated by using the 
QuikChange mutagenesis kit with Pfu DNA polymerase and the vector of pTrc-HPPD as template 
[41]. Two complementary primers including the desired mutations were used for PCR (Table S1). 
The variant-containing vectors were transformed into E. coli DH5 competent cells and the 
presence of the desired mutation was confirmed by DNA sequencing of the coding region. 
  
Protein purification  
The overexpression and purification of recombinant wild-type and variant HPPD enzymes 
were carried out as reported previously [41]. In brief, the supernatant of crude cell extract were 
loaded onto Q-Sepharose anion exchanger column (26 x 150 mm) equilibrated in 50 mM Tris-HCl 
buffer, pH 7.5, 1 mM EDTA and 1 mM DTT, and eluted with the same buffer. Ammonium sulfate 
stock solution was added to pooled fractions to give a final concentration of 1.2 M, and the 
solution was loaded onto a hydrophobic interaction column (Source™ 15PHE, 16 x 100 mm) 
pre-equilibrated in buffer containing 10% (v/v) glycerol and 1.2 M ammonium sulfate. Protein 
was eluted with a 1.2 – 0 M ammonium sulfate gradient. The pooled fractions were loaded onto 
S-100 Sephacryl column (26 x 900 mm) equilibrated with 50 mM Tris-HCl buffer, pH 7.5. 
Fractions exhibited the highest purity protein, as determined by 10% SDS-PAGE were pooled and 
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concentrated. Protein concentrations are determined by the method of Bradford [42]. The mass of 
the purified proteins were analyzed by Mass Spectrometry to confirm the mutation. The metal 
contents of the purified proteins were determined using inductively coupled plasma-high 
resolution mass spectrometry (ICPMS) (Perkin Elmer NexION 300S). The metal contents of 
buffer were also measured for correction. 
 
Enzyme activity measurements 
The activity of HPPD was measured using both the Oxygraph and HPLC assays [41]. The 
oxygen consumption assay was performed in an Oxygraph apparatus equipped with a Clark-type 
electrode (Hansatech, U.K.). The reaction mixtures containing 5 g HPPD, 0.2 mM ascorbate 
and 0.2 mM FeSO4 in 0.1 M Tris-acetate buffer, pH 6.5, which were incubated for 1 min at 37 oC, 
followed by addition of 1 mM HPP to initiate the measurement. The oxygen consumption rates 
were corrected for the reaction without enzyme. The kinetic assays were carried out at variable 
concentrations of HPP (0.01 to 2 mM) or FeSO4 (0.01 to 0.4 mM). 
The HPLC assay is used to determine HG product formation. Reaction mixtures containing 
5 g of HPPD, 1 mM ascorbate, 1 mM FeSO4, 1 mM HPP in 0.1 M Tris-acetate, pH 6.5, were 
incubated for 5 min at 37 oC with shaking. Following by filtration using centrifugation at 8000 g 
(Amicon Ultra-0.5, 10 kDa) to remove the protein, the product was analyzed by HPLC on a C18 
column (4.6 x 250 mm, 5-m particle size; ODS HYPERSIL) at a flow rate of 1 mL/min. The 
solvents used were 0.1% TFA (v/v) for buffer A and 80% acetonitrile (v/v) /0.07% TFA (v/v) for 
buffer B following the elution conditions reported previously [41]. The elution of product was 
monitored at 230 nm [29]. The eluted product of HG and HPA were identified using the mass 
spectrometry (Waters 2695 separation module and Micromass ZQ). 
 
Mass spectrometry measurements 
 Wild-type, H183A, H266A, or E349Q variant proteins were collected after the reaction 
containing 1 mM HPP or not, and subjected to electrophoresis on a denaturing polyacrylamide 
gel and stain using Coomassie Brilliant Blue R-250. The protein bands in the gel were excised 
and in-gel digestion performed according to the reported protocol [43]. In brief, the gel pieces 
were washed with aq. ammonium bicarbonate (25 mM) in methanol [40% (v/v)] and acetonitrile 
[50% (v/v)], reduced with dithiothreitol (10 mM) for 30 min at 56 oC and alkylated with 
iodoacetamide (50 mM) in aq. ammonium bicarbonate (50 mM) for 30 min in the dark. The gel 
pieces were washed and dried in a SpeedVac, and incubated with 10 L of trypsin solution (12.5 
ng/L) in aq. ammonium bicarbonate (25 mM) and acetonitrile [10% (v/v)] for 16 hrs at 37 oC. 
The peptides were extracted with formic acid [5% (v/v)] in acetonitrile [50% (v/v)] and dried in a 
SpeedVac. Peptides were resuspended in acetonitrile [50% (v/v)] supplemented with formic acid 
[0.1% (v/v)] and mixed (1:1) with the matrix solution (5 mg/mL of 2,5-dihydroxybenzoic acid in 
the same solution), and then spotted onto a target plate and left to dry. The samples were 
analyzed using a MALDI TOF/TOF mass spectrometer (Bruker AutoflexIII, Breman, Germany) 
equipped with a 200 Hz SmartBean Laser in positive ion mode with delayed extraction in the 
reflector mode. The FlexControl and Flex-Analysis (Bruker Daltonik, version 3.0) were used for 
data acquisition and processing. Mascot search engine (Matrix Science, UK) combined with 
peptide mass fingerprinting and MS/MS datasets were performed for protein database searches 
via Biotools 3.1 (Bruker).  
  
Isothermal titration calorimetry (ITC) measurements 
 The binding affinity of metal ion with wild-type and variant HPPD were determined using 
the iTC200 calorimeters (MicroCal, Northampton, MA). Titrations were performed at 298 oK by 
injection of 1-2 L of CoCl2 into 200 L of proteins in 50 mM Tris-HCl buffer, pH 7.5. The 
interval between each injection was 200 s to allow the system to reach equilibrium. The heat of 
each ligand dilution experiment were measured in separate runs and subtracted from the 
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experimental heat of protein-CoCl2 titration. Integrated heat from each injection was analyzed 
using the MicroCal Origin software (version 7.0) by fitting the data to a one-site binding model. 
 
Building of variant models 
 All simulations were performed using the Discovery Studio 4.5 software (Accelrys Inc.). 
The modelled structure of human HPPD (PDB code: 3ISQ) [32] in complex with HPP and 
dioxygen was used as the template to generate the models of variant HPPD using the Built 
Mutants protocol followed by energy minimization with the algorithm of smart minimization until 
the gradient tolerance was satisfied (RMS Gradient ~ 0.1 kcal/mol/Å). They were then applied to 
the QM/MM calculations using the Minimization (QM-MM) protocol. Residues located outside 5 
Å distance of 4-HPP were set with atom constraints. The metal ion, HPP, dioxygen and the 
side-chains of H183, H266, and E349 were defined as the quantum atoms. The electronic spin 
state in DMol3 was set as “auto”. The PBE function and coarse convergence criteria were used in 
DMol3 settings. All other parameters of the protocol were used with their default settings. 
 Molecular Dynamics (MD) simulations were run with the standard dynamics cascade 
protocol in the CHARMm force field. The complexed structures of wild-type and variant HPPD 
were energy minimized using the QM-MM protocol and solvated in an orthorhombic box with a 
minimum distance of 7 Å from the boundary using the Explicit Periodic Boundary model. 
Counter ions (Na+ and Cl- ions) were added to neutralize the system. All atoms of the protein 
complex was set constraint, then the whole system was subjected to energy minimization for 
1000 steps by Steepest Descent followed by Adopted Basis NR for 2000 steps. Heating of the 
system were carried out from 50 to 300 oK in 2 ps MD simulations followed by equilibration for 2 
ps at 300 oK. Simulation in the production phase employed the Berendsen coupling algorithm for 
100 ps at NVT without any atom constraints. All bonds involving hydrogens in the simulation 
were constrained by the Shake algorithm. The resulted trajectories after MD were selected to run 
energy minimization by QM-MM protocol. 
 
Results 
Activity of wild-type and variant enzymes  
Purification of recombinant wild-type and variant HPPD yielded a pure protein, as judged 
by SDS-PAGE. The metal content that measured in the purified proteins was very low (≤ 0.05 
atoms/monomer) (Table S2) [44]. Circular dichroism analysis showed no gross changes in the 
secondary structure of enzymes after mutation of these residues (Fig. S1). Using oxygen 
consumption as a measure of activity, the specific activity of the H183A and H266A variants 
were about 5 and 10% of the wild-type enzyme, respectively. No detectable activity was 
observed for the E349A variant (Table 1). In contrast, the E349G and E349Q variants retained 
about 5% of the activity of the wild-type enzyme.  
 The steady-state kinetics of HPPD variants were characterized by the rate of oxygen 
consumption at various concentrations of HPP or metal (Table 2 and Fig. S2). As compared to 
wild-type enzyme, the KM values of HPP for H183A and E349G variants are decreased by ca. 
2-fold, and with a 2-fold increase for the E349Q variant. However, kcat values were reduced by 
>90% for all variants (Table 2). The kcat/KM values were decreased by about 9-, 23-, 27- and 
32-fold for H183A, H266A, E349G and E349Q variants, respectively, compared to the wild-type 
enzyme. It seems that a large reduction in the catalytic efficiency has occurred as a result of these 
mutations. 
The activity of wild-type and variant HPPD at variable concentration of Fe2+ or Co2+ 
performed a saturation curve (Fig. S2). As compared with wild-type enzyme, no significant 
changes in the KdFe values for the ferrous ion were observed for the H183A and H266A variants, 
whilst it was increased approximately 7- and 3-fold for the E349G and E349Q variants, 
respectively (Table 2). When replacing of Fe2+ with Co2+, the KdCo value was decreased by about 
30-fold. It seems that the enzyme has a higher binding affinity for Co2+ than Fe2+ but a lower 
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activity when using this metal as cofactor. The activity performed in Co2+ substituted HPPD was 
consistent with the extradiol-cleaving catechol dioxygenase [45]. 
 
Product analysis of wild-type and variant enzymes 
 The HG product formation was analyzed using the HPLC assay. The specific activities of 
the H183A, E349G and E349Q variants were about 1, 5 and 1% of the wild-type enzyme, 
respectively, whilst no detectable activity was observed for the H266A and E349A variants 
(Table 1). It is noted that the specific activity for the H183A and E349Q variants as measured by 
oxygen consumption is 5-fold higher than that measured by HPLC assay, implying only 20% of 
catalytic cycles are coupled in these variants. No product formation was observed for the H266A 
variant. This is due to the formation of a stable HPA intermediate rather than the expected HG 
product. HPLC analysis of the reaction products for the H266A variant confirmed the presence 
of the HPA intermediate at a retention time of 12.4 minutes (Fig. 2). The amount of the HPA 
product increased with increasing reaction time and enzyme concentration (Fig. S3). The specific 
activity for this reaction was calculated from the integrated area of HPA to be ca. 0.01 ± 0.004 
mol/min/mg. It is noted that HPA was not produced from the H183A or E349Q variant enzymes, 
even at greatly extended reaction times or greatly increased enzyme concentrations.  
 
Protein fragmentation after oxidative reaction of variant enzyme 
 To investigate the possible oxidative modification of the variant enzymes, protein samples 
from the assay were analyzed by SDS electrophoresis. In the H183A variant an additional band 
at ca. 30 KDa. was observed following incubation with HPP substrate. This fragment was not 
observed when HPP was omitted from the assay (Fig. 3). This new band accounts for about 10% 
of the total protein, as judged from the intensity of the band observed by SDS-PAGE analysis. 
The N-terminal sequence of this new band was determined to be the same as that of intact 
H183A variant protein, implying it is an N-terminal fragment. The new band was isolated from 
the gel and subjected to trypsin hydrolysis and MS/MS analysis (Fig. 4). When compared to the 
peptide mass fingerprint of the wild-type enzyme, an extra peak at m/z of 1977.97 was observed, 
which corresponds to the peptide sequence 250SQIQEYVDYNGGAGVQHI267. This suggests the 
Ile267 is at the carboxyl end of the fragment which is cleaved from the variant protein during the 
catalytic reaction.  
 
Isothermal titration calorimetry analysis 
 ITC was employed to analysis the metal binding properties of wild-type and variant HPPD. 
All measurements were carried out by titration of Co2+ into the protein to avoid the problem 
caused by the oxidation of Fe2+ in buffer. This ion is also the coordinating metal in the reported 
X-ray crystal structure of human HPPD [32] and allows some catalytic activity (Table 3). The 
titration experiment resulted in an exothermic reaction and the integrated heat data of wild-type 
and variant enzymes were fitted into a one-site binding model (Fig. 5). Based on at least three 
separate experiments, the averaged dissociation constants for wild-type, H266A, E349A, E349G 
and E349Q variants were 0.023 ± 0.004, 0.15 ± 0.02, 0.22 ± 0.03, 0.54 ± 0.05 and 0.37 ± 0.11 
mM, respectively (Table 3). Dissociation constant could not be measured for the H183A variant 
because of the low levels of expression of this variant. ITC analysis showed that the binding 
affinities of H266A, E349A, E349G and E349Q variants with the Co2+ were weaker by about 7-, 
10, 23- and 16-fold, respectively, than that determined for wild-type enzyme. The binding of 
these enzymes with the metal is primarily enthalpy-driven (Ho) (data not shown). The standard 
free energy differences (Go) were calculated to be about 1.1, 1.3, 1.8 and 1.6 kcal/mol for the 
H266A, E349A, E349G and E349Q variants, respectively, by subtraction of the value derived for 
the wild-type enzyme.  
 
Modeling of wild-type and variant HPPD 
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Wild-type, H183A, H266A, E349Q and E349G variant HPPD in complex with HPP and O2 
were modeled and geometrically minimized by QM-MM calculation. However, energy 
minimization by QM-MM protocol was not successful for the model of the E349A variant. In the 
simulated model of wild-type enzyme, E349, H266 and H183 coordinate in trans to O2, and the 
oxygen atoms of carboxylate and keto group of HPP, respectively (Fig. 6). The distance 
measured from the NE2 of H183, NE2 of H266, OE1 of E349, O1 of O2, and the oxygen atoms 
of the carboxylate and oxo groups of HPP to the metal were about 2.0, 2.05, 1.95, 1.90, 1.91 and 
1.98 Å, respectively. The bond length between two oxygen atoms of O2 was lengthened from 0.89 
to 1.4 Å. Both atoms carry a partial negative charge with the distal oxygen located near the carbon 
atom of the keto group of HPP at a distance about 2.43 Å. The OE1 of the carboxyl group and 
4-hydroxyl group of HPP form hydrogen bonds with the NE2 of Q334 and OE1 of Q251, 
respectively. 
No major changes in the positions of the Catomsof the H183A, H266A, E349Q and E349G 
variants was observed compared to wild-type enzyme. However, movements in the side-chains of 
H183, H266, E349, Q334, F359 and F364 in the active site were observed (Fig. 6). The positions of 
the metal ion, dioxygen and HPP were also shifted in these variant HPPD enzymes. The distance 
between two oxygen atoms of O2 in these variant enzymes was lengthened as wild-type. The 
proximal oxygen of O2 comes close to the metal with the distance about 1.84, 1.83 1.89 and 1.82 
Å, and about 2.56, 2.34 2.66 and 2.18 Å between the distal oxygen and the carbon atom of the 
oxo group of HPP in the H183A, H266A E349Q and E349G variants, respectively. It is noted 
that the shift of E349 in H266A variant leads to both oxygen atoms of the carboxylate group to 
coordinate to the metal. This movement also causes the NE2 of Q334 to form hydrogen bond 
with the OE2 of the carboxyl group of HPP. For the E349Q variant, the amide group of Q349 
was rotated about 90 degrees and shifts about 0.78 Å to form hydrogen bonding with the oxo 
group of HPP. Notably, the empty site in E349G variant was occupied by a water molecule, 
which coordinates with the metal at a distance of about 2.06 Å.   
From the Molecular Dynamics (MD) simulation, conformations of H183A variant were 
selected for geometrically minimization through QM-MM calculation. One conformation with 
successful energy minimization showed a different coordination manner between the dioxygen 
and metal as compared to the model before MD simulation (Fig.6B and C). It is noted that the 
shift of E349 leads to both oxygen atoms in the carboxylate group to coordinate with the metal. 
The proximal oxygen of O2 comes close to the metal at a distance of about 1.83 Å but the distal 
oxygen placed in a direction away from HPP (Fig. 6C). The distance of the distal oxygen with the 
carbonyl carbon of I267, the HD2 of H266 and the HB2 of A268 were about 5.07, 3.3 and 2.55 Å, 
respectively. 
  
Discussion 
 The strictly conservative structure of human HPPD contains a 2-His-1-Glu facial triad to 
anchor the Fe2+ into the active site for catalysis [32]. The present study demonstrates that 
mutating the side-chains of the three selected residues resulted in a considerable reduction in 
enzyme activity. The E349A mutation, in particular, diminished the activity as measured by both 
oxygen consumption and HG production. The results highlight the vital role of E349 in enzyme 
function. It is noted that in the absence of HPP, the metal is still bound in the E349A variant 
protein suggesting that two His residues are sufficient for iron binding consistent with the report 
for the analogous D201A variant in FIH [27]. However, in HPPD catalytic activity is lost (Table 
1). Hence, the carboxylate group of the ligand in the coordination is suggested to be essential for 
Fe2+ binding and subsequently activation of the dioxygen upon substrate binding, the initial step 
for oxygenase activity of HPPD [19, 39, 40].  
It is interesting that the E349G variant possesses residual activity although glycine contains 
no side-chain to bind with Fe2+. The space left in this site is assumed to enable a water molecule 
to coordinate with the iron as observed in the crystal structure of the FIH D201G variant complex 
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[27]. The hydroxylation activity performed on the variant FIH suggests that a bound water 
molecule is able to fulfill this function. Although the E349G variant HPPD exhibited weak 
binding affinity with metal, the coordinated water molecule which located in trans to the 
dioxygen molecule, as shown in the simulated model (Fig. 6A), seems to be able to support the 
activation of dioxygen when substrate is bound and couples decarboxylation and HG product 
formation. 
Substitution of the metal binding ligand might impact on the interaction of the reactive 
oxygen intermediate in the catalytic reaction. It is noted that although the variants of H183A, 
H266A and E349Q exhibited residue activity (~5-10% of wild-type enzyme), their activities 
measured by oxygen consumption and HG product were not equivalent suggesting a significant 
amount of uncoupled reaction (Table 1). The uncoupled reaction catalyzed by H266A variant 
produces the HPA intermediate in place of HG product (Fig. 2). In the modeled structure, the 
H266A variant showed a different coordination environment around the metal, in particular the 
additional coordination from E349 and the interaction of the side-chain of Q334 with HPP (Fig. 
6A). These changes might reduce efficient activation of dioxygen by Fe2+ for the initial 
nucleophilic reaction with the 2-oxo group of HPP. The change in coordination appears to impact 
on the correct orientation of the Fe(IV)-oxo intermediate for hydroxylation in the aromatic 
side-chain of HPA. Hence, H266 is assumed to play the role in regulating the geometry of 
reactive oxygen intermediate for coupling the decarboxylation and hydroxylation reactions. 
The mechanism in the uncoupled reaction catalyzed by H183A and E349Q variants seems 
to be different because no HPA or other product derived from HPP was measured in the reaction 
solution. Self-hydroxylation is catalyzed by several 2-OG dependent Fe(II) oxygenase, which 
results in modification of Phe, Tyr or Trp residues located near the active site in the presence of 
2-OG but not the primary substrate [46-49]. Isotope labeling experiments suggests the 
involvement of an Fe(VI)-oxo intermediate in the process and assumes that this reaction is a 
strategy to protect the enzyme from severe peptide cleavage [46]. However, no hydroxylated 
residues in the H266A or E349Q variant active sites were observed by MS/MS analysis 
following reaction in the presence of HPP substrate, suggesting that this uncoupled reaction is 
unlikely to be a self-inactivation process.  
Protein fragmentation was observed following the oxidative reaction catalyzed by H183A 
variant. This suggests an alternative reactivity of the reactive oxygen intermediate in protein 
molecule (Fig. 3) [40]. In this reaction the peptide bond between Ile267 and Ala268 in HPPD was 
cleaved, which is at a site close to H266. Interestingly, the site for the modified tryptophan 
residue that generated by self-hydroxylation of 2,4-dichlorophenoxyacetate/2-OG dioxygenase 
(TfdA) in the presence of cofactor but not substrate is also located adjacent to His113, the 
equivalent metal-binding ligand [46]. These results reveal the potential sites for side reaction 
through metal-mediated oxidation. Oxidative fragmentation was also reported for 
1-aminocyclopropane-1-carboxylate (ACC) oxidase, which utilizes ascorbate but not a 2-oxoacid 
as a cosubstrate in the enzyme catalyzed reaction [50]. Fragmentation in ACC oxidase increased 
following modification of the metal-binding ligands [50].  
Modeling studies on the dioxygen bound HPPD H183A complex suggests that two different 
dioxygen binding modes are possible. In these two modes, the distal oxygen atom is located 
either facing towards or away from the HPP (Fig. 6B and C, respectively). Thus, substitution at 
H183 seems to increase the flexibility in the coordination centre leading to the dynamic 
behaviour of the reactive oxygen intermediate in the reaction [18]. The exact mechanism for the 
protein fragmentation by the reactive oxygen intermediate remains unclear. However, the 
irreversible destruction in the H183A variant protein after the oxidative reaction process suggests 
that this ligand plays an important role in metal ion coordination and hence determines the 
appropriate orientation of the reactive oxygen intermediate in the oxidative reaction. This appears 
to be critical for protection of the protein from damage by alternative oxidative reactions. 
 In the modeled structures, the oxygen atoms in the carboxyl group of E349 take over the 
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coordination when either H266 or H183 are substituted. This explains the residual activities 
performed by both variant enzymes and also demonstrated that one Glu and one His are 
sufficient for HPPD activity. These results contrast with the mutagenesis study on FIH, which 
suggests that two His residues is required for iron function [27]. This highlights the different 
roles of each metal binding ligand that acts in the catalysis reaction of HPPD and 
2-oxoglutarate-dependent oxygenases. This difference might due to the inclusion of an oxoacid 
moiety within the HPP substrate. In the FIH structure, the position for 2-OG co-substrate to 
bidentate coordinated in other dioxygenase is located perpendicular to the Glu and one His 
ligand, respectively, and the dioxygen is presumed to occupy the sixth binding site trans to a His 
ligand [14, 37, 51]. However, rearrangement of the Fe(VI)-oxo intermediate is required for 
correct orientation towards the prime substrate that is bound in the vicinity of the metal binding 
sphere [37, 52]. For HPPD, the coordination site of the dioxygen and the oxo-group of the 
intermediate seem to stay at the same place, perpendicular to the Glu ligand [38]. This result 
suggests some flexibility in the metal centered coordination for various chemical transformations. 
For HPPD, a single 2-oxoacid substrate which coordinates to the metal centre seems to be 
sufficient for completion of a complicated catalytic reaction. 
Substitution in the facial triad of HPPD resulted in about 10-fold reduction in the affinity 
with metal as measured by ITC (Table 3). From the Kd values for Fe2+ in the activity assay, it was 
noted that only the reaction catalyzed by E349G and E349Q variants were significantly increased 
(Table 2). However, the KM values for HPP in the catalytic reaction of these variants is similar to 
the wild-type enzyme whilst the catalytic efficiencies were substantially reduced (Table 2). The 
results highlight the critical role of ligand coordination in stabilization of the metal for the 
catalytic reaction. The different nature of mutation led to the loss of activity for E349A, and the 
E349G and E349Q mutants that retain residual activity but different kinetic parameter highlight 
the critical role of the carboxylate group of E349 in metal coordination. Substitution might 
impact the charge transfer ability from metal to the trans bound dioxygen when substrate is 
bound, which influences the reaction efficiency (Fig. 6) [38]. The reduction in the activity for 
H183A and H266A mutants were unlikely due to the water molecule which fills the empty space 
in the A183 or A266 mutation sites. It implies that the metal coordination by only the E349 and 
H183 or E349 and H266 is sufficient to retain the catalytic function of the enzyme; however, 
regulation of the reaction in coupled seems to impact. In this structural model, H266 is 
coordinated in cis position to HPP. The mutation appears to alter the efficient interaction of the 
oxygen intermediate with the phenyl moiety of HPA. However, H183 which is coordinated 
opposite to the oxo group of HPP seems to play a key role in controlling the oxidative 
intermediate to prevent self-damage. Therefore, this study reveals the distinct role of each metal 
binding ligand in the function of HPPD. The functions include controlling the initiation of the 
oxidative reaction, regulation of the oxygen intermediate during the coupled reaction and 
prevention of severe side reaction by E349, H266 and H183, respectively. These roles are 
correlated with their respective coordination positions with respect to bound dioxygen or HPP. 
. 
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Table 1. Specific activities for wild-type and variant HPPD 
 
 
Oxygen consumption 
(mol/min/mg) 
HG production 
(mol/min/mg) 
WT 2.1 ± 0.09 1.7 ± 0.08 
H183A 0.1 ± 0.02 0.02 ± 0.004 
H266A 0.2 ± 0.07 ND 
E349A ND ND 
E349G 0.09 ± 0.005 0.08 ± 0.01 
E349Q 0.1 ± 0.01 0.02 ± 0.002 
*The Oxygraph and HPLC were used to assay activity by measuring oxygen consumption and HG 
production, respectively. The reported values are means ± S.D. for three independent experiments. 
ND, no detectable activity. 
 
 
 
Table 2. Apparent kinetic parameters  
 HPP metal 
   kcat (s-1)    KM (mM)    kcat/KM  KdFe (mM)    KdCo(mM) 
WT 3.3 ± 0.4 0.2 ± 0.05 16 ± 3 0.03 ± 0.003 0.001 ± 0.0003 
H183A 0.16 ± 0.004 0.09 ± 0.004 1.8 ± 0.03 0.04 ± 0.006 - 
H266A 0.13 ± 0.01 0.18 ± 0.02 0.7 ± 0.04 0.04 ± 0.01 - 
E349G 0.05 ± 0.002 0.1 ± 0.01 0.6 ± 0.03 0.2 ± 0.03 - 
E349Q 0.2 ± 0.01 0.4 ± 0.1 0.5 ± 0.1 0.09 ± 0.02 - 
*The oxygen consumption was used to assay activity. The parameters for HPP and metal were 
obtained by the fitting the kinetic data to the Michaelis-Menten and saturation curve equation, 
respectively. The Kd is the binding constant that represents the metal concentration needed to 
achieve half value of the maxima velocity. The reported values are means ± S.D. for three 
independent experiments. 
 
 
 
 
Table 3. Binding constants of cobalt ion with wild-type and variant HPPD. 
 Kd (mM) G (kcal/mol)
WT 0.023 ± 0.004 -6.3 ± 0.1 
H266A 0.15 ± 0.02 -5.2 ± 0.1 
E349A 0.22 ± 0.03 -5.0 ± 0.1 
E349G 0.54 ± 0.05 -4.5 ± 0.1 
E349Q 0.37 ± 0.11 -4.7 ± 0.5 
The reported values are means ± S.D. for three independent experiments. 
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Figure legends  
Figure 1: (A) The proposed reaction mechanism catalyzed by human HPPD (hHPPD) [9]. (B) 
Sequence alignment of HPPD and homologous enzymes from different species. Fully 
conservative residues are highlighted and the facial triad is colored as dark grey. Location of 
these residues in the -strands, defined based on the topology of human HPPD structure (PDB 
code: 3ISQ), are rendered as arrows [32]. Abbreviations used: hHPPD, Homo sapiens (human) 
HPPD; rHPPD, Rattus norvegicus (rat) HPPD; saHPPD, Streptomyces avermitilis HPPD; 
atHPPD, Arabidopsis thaliana HPPD; aoHMS, Amycolatopsis orientalis HMS; zmHPPD, Zea 
mays HPPD; PfHPPD, Pseudomonas fluorescens 4-HPPD.   
 
Figure 2. HPLC analysis of the product formed by WT and variant HPPD. These assays are 
incubated at 30 oC for 5 min containing 30 g proteins. Control assay includes all reaction 
mixture except enzyme. The elution profile for standard HG and HPA were shown as dark and 
gray lines, respectively. 
 
Figure 3. SDS-PAGE analysis of HPPD variants after oxidative reaction. The solution for control 
(C) and reaction (R) experiments include 1 mM FeSO4, 1 mM ascorbate and 18 g protein in 0.1 
M Tris-acetate buffer, pH 6.5, in the absence and presence of 1 mM HPP, respectively. Reactions 
were carried out for 5 min at 30 oC. The additional band was highlighted as black rectangular 
line. 
 
Figure 4. MS/MS analysis of the tryptic peptide (Ser250-Ile267) obtained from H183A variant 
HPPD. The sample corresponding to the additional band as shown in Fig 3 was excised from the 
gel, digested with trypsin and submitted for MS/MS analysis. (A) The peptide mass fingerprint of 
the wild-type and the fragment from H183A variant. The additional peptide fragment is 
highlighted as arrow. (B) The spectrum shows the MS/MS sequencing at m/z of 1977.97 with 
singly charged y and b fragment ions. 
 
Figure 5. ITC analysis the binding of Co2+ to wild-type and variant HPPD. The upper panels 
show the calorimetric titration of 60, 83, 63 and 157 M of wild-type (A), H266A (B) and 
E349G (C) E349Q (D) variant HPPD with 1, 5, 10 and 20 mM of Co2+, respectively. The lower 
panels display the integrated heat data as a function of Co2+/protein molar ratio.  
 
Figure 6. The simulated models of wild-type and variant HPPD in complex with HPP and 
dioxygen. (A) Superimposition of the wild-type and H183A, H266A, E349Q and E349G variants 
that shown as stick models in green, cyan, yellow, magentas and gray, respectively. The metal, 
HPP and dioxygen is represented by a sphere and stick model, respectively. Hydrogen bond 
interactions are shown as dotted green lines. (B) and (C), the H183A variant. The protein is 
shown as cartoon and colored gray. HPP and dioxygen are shown as stick model and colored 
yellow and red, respectively. The red circle highlights the different orientation of ligands in the 
metal binding sphere. 
 
 
 
 
 






